News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Aldagen, Inc. Files for $80.5 Million IPO
October 29, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Trading Markets -- Biopharmaceutical company Aldagen Inc. filed for a $80.5 million initial public offering on Wednesday, reviving the bid it had withdrawn a year ago.
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
GLP-1
Pfizer Builds Global GLP-1 Strategy With up to $495M Sciwind Deal
February 24, 2026
·
2 min read
·
Tristan Manalac
Collaboration
Astellas Bets up to $1.7B for Vir’s ‘Robust Competitor’ in Prostate Cancer
February 24, 2026
·
2 min read
·
Tristan Manalac
IPO tracker
Generate’s IPO Could Reach $425M, Largest Raise Yet
February 24, 2026
·
5 min read
·
Tristan Manalac
Mergers & acquisitions
Gilead Doubles Down on CAR T With $7.8B Arcellx Acquisition
February 23, 2026
·
2 min read
·
Tristan Manalac